Pharma companies must analyse the user experience of their websites to ensure continued patient engagement, and review their digital strategy frequently.
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS